Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN) received approval from the Food & Drug Administration (the "FDA") for Oxtellar XR , a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE